Lipid Panel Test Market

Lipid Panel Test (LPT), or total lipid profile or lipid panel is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, such as cholesterol and triglycerides. This test enables diagnosis of lipid disorders along with risk for coronary heart disease. There is a high correlation between coronary heart diseases (CHD) with abnormal lipid levels. These tests provides value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL. LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases.

Lipid Panel Test Market contains market size and forecasts of Lipid Panel Test in Global, including the following market information:

• Global Lipid Panel Test Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Lipid Panel Test market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hyperlipidemia Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lipid Panel Test include Abbott Laboratories, Avanti Polar Lipids, Inc., Beckman Coulter, Inc., EuroMedixPOC, F. Hoffmann-La Roche Ltd, Alere Inc., PTS Diagnostics, Quest Diagnostics and Randox Laboratories Ltd and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lipid Panel Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lipid Panel Test Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lipid Panel Test Market Segment Percentages, by Type, 2021 (%)

• Hyperlipidemia
• Hypertriglyceridemia
• Familial Hypercholesterolemia
• Hyperlipoproteinemia
• Tangier Disease
• Others

Global Lipid Panel Test Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lipid Panel Test Market Segment Percentages, by Application, 2021 (%)

• Home
• Diagnostic Laboratories
• Hospital

Global Lipid Panel Test Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lipid Panel Test Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Lipid Panel Test revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Lipid Panel Test revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Avanti Polar Lipids, Inc.
• Beckman Coulter, Inc.
• EuroMedixPOC
• F. Hoffmann-La Roche Ltd
• Alere Inc.
• PTS Diagnostics
• Quest Diagnostics
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc